| Variables | Population recruited in Cotonou | Population recruited in Dakar | ||||||||||||
| Men | Women | Total | Men | Women | Total | |||||||||
| N | % (CI) 95% | N | % (CI) 95% | N | % (CI) 95% | N | % (CI) 95% | |||||||
| Total | 89 | 38 [0.31; 0.45] | 145 | 62 [0.55; 0.69] | 234 | 112 | 47.46 [0.40; 0.54] | 124 | 52.54 [0.45; 0.59] | 236 | ||||
| Seroprotection markers N = 394 | ||||||||||||||
| anti HBs Ab | 71 | 34.6 [0.28; 0.41] | 134 | 65.4 [0.58; 0.72] | 205 | 81 | 42.9 [0.36; 0.50] | 108 | 57.1 [0.50; 0.64] | 189 | ||||
| Seroprotected individuals: Anti HBs Ab ≥ 10 IU/L | 32 | 43.8 [0.37; 0.51] |
41 | 56.2 [0.49; 0.63] | 73 | 48 | 41.4 [0.34; 0.48] | 68 | 58.6 [0.51; 0.66] | 116 | ||||
| Non seroprotected individuals: AntiHBs Ab < 10 IU/L (non zero) | 30 | 27.5 [0.21; 0.35] |
79 | 72.5 [0.66; 0.80] | 109 | 33 | 47.1 [0.41; 0.55] | 37 | 52.9 [0.46; 0.60] | 70 | ||||
| Non infected and unvaccinated individuals: Ag HBs and anti HBs Ab negative | 9 | 39.13 [0.26; 0.40] | 14 | 60.87 [0.60; 0.74] | 23 | 0 | 0 [-0.07; 0.07] | 3 | 100 [0.93; 1.07] | 3 | ||||